Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 EUR | +2.04% | +3.90% | +6.10% |
Feb. 14 | Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Nov. 22 | Biohit Names New Chief Commercial Officer | MT |
Sales 2024 * | 15.3M 16.5M | Sales 2025 * | 17.4M 18.77M | Capitalization | 30.23M 32.6M |
---|---|---|---|---|---|
Net income 2024 * | 1M 1.08M | Net income 2025 * | 2M 2.16M | EV / Sales 2024 * | 1.43 x |
Net cash position 2024 * | 8.4M 9.06M | Net cash position 2025 * | 10M 10.79M | EV / Sales 2025 * | 1.16 x |
P/E ratio 2024 * |
15.4
x | P/E ratio 2025 * |
15.4
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.24% |
1 day | +2.04% | ||
1 week | +3.36% | ||
Current month | +3.36% | ||
1 month | +3.63% | ||
3 months | +4.17% | ||
Current year | +6.10% |
Managers | Title | Age | Since |
---|---|---|---|
Jussi Hahtela
CEO | Chief Executive Officer | 51 | 21-06-03 |
Jussi Sorvo
DFI | Director of Finance/CFO | 34 | 20-12-31 |
Panu Hendolin
CTO | Chief Tech/Sci/R&D Officer | 53 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 56 | 23-06-13 | |
Founder | 81 | 87-12-31 | |
Director/Board Member | 73 | 19-04-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2 | +2.04% | 17,606 |
24-03-27 | 1.96 | +2.35% | 16,881 |
24-03-26 | 1.915 | +0.79% | 5,193 |
24-03-25 | 1.9 | -1.04% | 29,428 |
24-03-22 | 1.92 | -0.26% | 5,610 |
Delayed Quote Nasdaq Helsinki, March 28, 2024 at 12:12 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.10% | 32.05M | |
+6.95% | 8.49B | |
+8.85% | 5.19B | |
-6.52% | 2.93B | |
+0.23% | 2.14B | |
-18.72% | 1.24B | |
-48.64% | 795M | |
-12.51% | 795M | |
-18.74% | 774M | |
-22.09% | 669M |